Domenger, A., Choisy, C., Baron, L., Mayau, V., Perthame, E., Deriano, L., . . . Demangel, C. (2022). The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. Springer Nature.
Chicago Style (17th ed.) CitationDomenger, Antoine, et al. The Sec61 Translocon Is a Therapeutic Vulnerability in Multiple Myeloma. Springer Nature, 2022.
MLA (9th ed.) CitationDomenger, Antoine, et al. The Sec61 Translocon Is a Therapeutic Vulnerability in Multiple Myeloma. Springer Nature, 2022.
Warning: These citations may not always be 100% accurate.